Skip to main content
Caplight Logo









Thriva

Thriva

Private
LondonHealthcare & Life Scienceshttps://thriva.co/

Last Round

Series A

Extension

May 23, 2020

Total Funding Raised

$14.14M

Company Overview

Thriva is a health technology company that provides at-home, finger-prick blood testing services and personalized health insights to empower individuals to proactively manage their health.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Subscription Commerce, Healthcare Analytics

Business Model

B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

at-home blood testhealth trackingbiomarker monitoringdirect-to-consumer healthcorporate wellnessdigital health platformpreventative healthhealth diagnosticsremote testingpersonalized healthlab testing APIhealth techfemtechbiohackinglongevity tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Thriva Comparables

Compare Thriva with similar companies based on industry and business-model similarity.

Thriva comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medichecks
90%
Forth
87%
London Medical Laboratory
87%

Thriva Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 23, 2020
Series AJul 29, 2019
SeedJun 13, 2017

Key People

Founding team and executive leadership

Hamish Grierson

CEO & Co-Founder

Founding Team

Thriva Investors

Notable investors and investment history

Thriva investors
InvestorRounds
Guinness Asset ManagementSeries A, Series A Extension
500 GlobalSeed
Target GlobalSeries A Extension
Funding LondonSeed
Pembroke VCTSeries A, Series A Extension
SeedcampSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2025

    Will use Tasso's blood testing technology to address needle phobia.

  • Jul 29, 2019

    $7.3M round with Guinness Asset Management and Pembroke VCT.

Thriva Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Thriva Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Thriva's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range53
Year Founded2015
Last FundingMay 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?